Breakdown | |||||
TTM | Dec 2024 | Dec 2023 | Dec 2022 | Dec 2021 | Dec 2020 |
---|---|---|---|---|---|
Income Statement | Total Revenue | ||||
5.19B | 5.00B | 4.30B | 3.94B | 3.44B | 3.03B | Gross Profit |
1.02B | 1.01B | 981.22M | 866.92M | 779.61M | 682.26M | EBIT |
331.99M | 321.83M | 314.60M | 240.23M | 190.84M | 110.75M | EBITDA |
405.10M | 407.65M | 483.16M | 345.81M | 255.93M | 182.66M | Net Income Common Stockholders |
213.77M | 211.82M | 267.09M | 150.56M | 139.90M | -8.08M |
Balance Sheet | Cash, Cash Equivalents and Short-Term Investments | ||||
171.37M | 412.56M | 343.85M | 294.19M | 119.42M | 99.27M | Total Assets |
3.31B | 3.42B | 3.22B | 3.11B | 2.79B | 2.65B | Total Debt |
1.22B | 1.22B | 1.17B | 1.08B | 1.06B | 1.12B | Net Debt |
1.05B | 805.41M | 822.56M | 789.40M | 940.48M | 1.02B | Total Liabilities |
1.96B | 2.02B | 1.80B | 1.73B | 1.62B | 1.63B | Stockholders Equity |
1.35B | 1.40B | 1.42B | 1.39B | 1.18B | 1.02B |
Cash Flow | Free Cash Flow | ||||
345.81M | 287.79M | 329.43M | 232.19M | 182.94M | 100.52M | Operating Cash Flow |
384.96M | 323.39M | 371.30M | 267.55M | 208.57M | 127.39M | Investing Cash Flow |
-157.34M | -36.47M | -56.51M | -108.05M | -111.54M | -26.33M | Financing Cash Flow |
-275.76M | -218.21M | -265.13M | 15.27M | -76.87M | -68.85M |
Name | Overall Rating | Market Cap | P/E Ratio | ROE | Dividend Yield | Revenue Growth | EPS Growth |
---|---|---|---|---|---|---|---|
78 Outperform | $5.14B | 25.09 | 15.38% | ― | 16.98% | -17.76% | |
78 Outperform | $8.31B | 27.16 | 17.66% | 0.17% | 16.80% | 39.99% | |
77 Outperform | $2.06B | 25.34 | 9.18% | ― | 11.38% | 10.29% | |
71 Outperform | $3.07B | 34.58 | 7.85% | ― | 5.34% | ― | |
68 Neutral | $11.98B | 24.55 | 25.33% | 0.56% | 11.21% | 30.38% | |
64 Neutral | $1.85B | 10.71 | 10.38% | 3.04% | -8.86% | -36.22% | |
53 Neutral | $5.14B | 3.23 | -45.01% | 2.85% | 17.55% | -0.69% |
At the 2025 Annual Meeting of Stockholders held on May 14, 2025, Option Care Health‘s Board of Directors approved amendments to the company’s Certificate of Incorporation and Bylaws. These changes include allowing stockholders to request special meetings, limiting monetary liability for certain officers, and removing outdated provisions related to HC Group. The stockholders also elected directors, ratified KPMG LLP as the accounting firm, and approved executive compensation, reflecting a strategic shift to enhance governance and shareholder rights.
The most recent analyst rating on (OPCH) stock is a Buy with a $33.00 price target. To see the full list of analyst forecasts on Option Care Health stock, see the OPCH Stock Forecast page.